SPRB Return on Tangible Equity | Spruce Biosciences, Inc.

Spruce Biosciences, Inc. (SPRB) Return on Tangible Equity

2026-06-30: Return Tang Equity -61.33%.
2026-03-31: Return Tang Equity -107.34%.
2025-12-31: Return Tang Equity -91.65%.
2025-09-30: Return Tang Equity -888.95%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-61.33%
2026-03-31	-107.34%
2025-12-31	-91.65%
2025-09-30	-888.95%
2025-06-30	-366.75%
2025-03-31	-361.86%
2024-12-31	-184.02%
2024-09-30	-76.35%
2024-06-30	-72.86%
2024-03-31	-70.17%
2023-12-31	-62.63%
2023-09-30	-57.52%
2023-06-30	-49.88%
2023-03-31	-43.71%
2022-12-31	-67.43%
2022-09-30	-56.35%
2022-06-30	-49.67%
2022-03-31	-44.06%
2021-12-31	-37.97%
2021-09-30	-34.62%
2021-06-30	-30.43%
2021-03-31	-24.34%
2020-12-31	-19.77%
2020-09-30	47.40%
2020-06-30	41.19%
2020-03-31	39.52%
2019-12-31	42.72%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-91.65%
2024-12-31	-184.02%
2023-12-31	-62.63%
2022-12-31	-67.43%
2021-12-31	-37.97%
2020-12-31	-19.77%
2019-12-31	42.72%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Korro Bio, Inc. (KRRO)	United States	$0.141B	-1.81
Atrium Therapeutics, Inc. (RNA)	United States	$0.140B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)	United States	$0.144B	-1.72
Curanex Pharmaceuticals Inc (CURX)	United States	$0.138B
Annexon, Inc. (ANNX)	United States	$0.147B	-4.22
TuHURA Biosciences, Inc./NV (HURA)	United States	$0.134B	-4.88
Unicycive Therapeutics, Inc. (UNCY)	United States	$0.134B	-3.70
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
IMMUNIC, INC. (IMUX)	United States	$0.127B	-1.88